Skip to main content
. 2023 Jun 14;17:1067098. doi: 10.3389/fnins.2023.1067098

Figure 3.

Figure 3

Combined groups. Intervention effect measured as the relation between changes in HbA1c after 6 months of intervention and baseline HbA1c with experimental and conventional treatment group members pooled, including individuals with a predefined minimum reduction of PPS ≥ 15 at the end of the intervention period (i.e., PPS reverters; N = 52), and individuals without this reduction (PPS non-reverters; N = 60). (A) shows PPS non-reverters. (B) shows PPS reverters (between-group difference signifcant at P < 0.0001). Regarding HbA1c change depicted on the y-axis, a positive value reflects a reduction in HbA1c.